First Oral COVID-19 Vaccine Fact checked by Robert Carlson, MD+...

  1. 5,523 Posts.
    lightbulb Created with Sketch. 31

    First Oral COVID-19 Vaccine

    Vaxart coronavirus vaccine is a room temperature stable tablet
    depicition of the virus

    A South San Francisco based biotechnology company announced that its oral COVID-19 vaccine candidate has been selected to participate in a non-human primate (NHP) challenge study, organized and funded by the U.S. government’s Operation Warp Speed.

    Operation Warp Speed (OWS) is a national effort to accelerate the development, manufacturing, and distribution of a COVID-19 vaccine.


    On June 26, 2020, Vaxart, Inc., stated this study is designed to demonstrate the efficacy of Vaxart’s oral COVID-19 vaccine in humans.

    “We are very pleased to be one of the few companies selected by Operation Warp Speed, and that ours is the only oral vaccine being evaluated,” said Andrei Floroiu, Chief Executive Officer of Vaxart Inc., in a related press release.


    “SARS-CoV-2, the coronavirus that causes COVID-19, is primarily transmitted by viral particles that enter through the mucosa - nose, mouth, or eyes - strongly suggesting that mucosal immunity could serve as the first line of defense.”

    “In addition, our vaccine is a room temperature-stable tablet, an enormous logistical advantage in large vaccination campaigns.”

    https://www.precisionvaccinations.com/first-oral-covid-19-vaccine-selected-operation-warp-speed

 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.